Inflammatory Muscle Diseases

被引:452
|
作者
Dalakas, Marinos C. [1 ,2 ]
机构
[1] Thomas Jefferson Univ, Dept Neurol, Neuromuscular Div, Philadelphia, PA 19107 USA
[2] Univ Athens, Sch Med, Neuroimmunol Unit, GR-10679 Athens, Greece
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2015年 / 372卷 / 18期
关键词
INCLUSION-BODY MYOSITIS; CYTOSOLIC 5'-NUCLEOTIDASE 1A; T-CELL-RECEPTOR; JUVENILE DERMATOMYOSITIS; NECROTIZING MYOPATHIES; LASER-MICRODISSECTION; CLONAL EXPANSION; REFRACTORY ADULT; DOUBLE-BLIND; POLYMYOSITIS;
D O I
10.1056/NEJMra1402225
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
INFLAMMATORY MYOPATHIES ARE THE LARGEST GROUP OF POTENTIALLY treatable myopathies in children and adults. They constitute a heterogeneous group of disorders that are best classified, on the basis of distinct clinicopathologic features, in four subtypes: dermatomyositis, polymyositis, necrotizing autoimmune myositis, and inclusion-body myositis (throughout this review, I use this term to refer specifically to sporadic inclusion-body myositis). 1-6 A fifth subtype, termed overlap myositis, is also beginning to be recognized. The identification of the correct subtype and the distinction of these conditions from other diseases that have characteristics that mimic these conditions is fundamental, because each subtype has a different prognosis and response to therapies. This review reflects the current knowledge of these conditions, highlights how best to avoid erroneous diagnoses, describes the main clinicopathologic and immunologic features, and provides practical guidelines regarding therapies.
引用
收藏
页码:1734 / 1747
页数:14
相关论文
共 50 条
  • [21] Chronic Inflammatory Muscle Diseases and Risk of Coronary Artery Disease
    Gundogdu, Betul M.
    Cilingiroglu, Mehmet
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2013, 15 (03)
  • [22] Entzündliche Muskelerkrankungen (Myositiden)Inflammatory muscle diseases (myositis)
    M. Vahlensieck
    [J]. Der Radiologe, 2017, 57 (12): : 1052 - 1058
  • [23] Genetic factors and immune mechanisms in idiopathic inflammatory muscle diseases
    Garlepp, MJ
    Kok, CC
    Mastaglia, FL
    [J]. BRAIN PATHOLOGY, 1997, 7 (04) : 1041 - 1041
  • [24] Inflammatory muscle diseases: dermatomyositis, polymyositis, and inclusion body myositis
    Genth, E
    [J]. INTERNIST, 2005, 46 (11): : 1218 - +
  • [25] Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases
    Bruni, Cosimo
    Cigolini, Cosimo
    Tesei, Giulia
    Cometi, Laura
    Bartoli, Francesca
    Fiori, Ginevra
    Nacci, Francesca
    Randone, Silvia Bellando
    Guiducci, Serena
    Cerinic, Marco Matucci
    [J]. EUROPEAN JOURNAL OF RHEUMATOLOGY, 2021, 8 (04) : 190 - 195
  • [26] MRI findings in inflammatory muscle diseases and their noninflammatory mimics. Commentary
    Cerezal, L.
    [J]. RADIOLOGIA, 2009, 51 (06): : 547 - 548
  • [27] Expression of TDP-43 in inflammatory myopathies and other muscle diseases
    Ishii, A.
    Takuma, H.
    Tsuji, H.
    Ohkoshi, N.
    Tamaoka, A.
    [J]. NEUROMUSCULAR DISORDERS, 2009, 19 (8-9) : 651 - 651
  • [28] Significance of endomyocardial biopsy in the diagnosis and treatment of inflammatory heart muscle diseases
    Pankuweit, Sabine
    Funck, Reinhard
    Grimm, Wolfram
    Maisch, Bernhard
    [J]. HERZ, 2006, 31 (04) : 361 - 365
  • [29] CHRONIC INFLAMMATORY LESIONS OF SKELETAL MUSCLE IN RHEUMATOID ARTHRITIS AND IN OTHER DISEASES
    OGRYZLO, MA
    [J]. ARCHIVES OF PATHOLOGY, 1948, 46 (04): : 301 - 312
  • [30] Vitamin D and Muscle Status in Inflammatory and Autoimmune Rheumatic Diseases: An Update
    Hysa, Elvis
    Gotelli, Emanuele
    Campitiello, Rosanna
    Paolino, Sabrina
    Pizzorni, Carmen
    Casabella, Andrea
    Sulli, Alberto
    Smith, Vanessa
    Cutolo, Maurizio
    [J]. NUTRIENTS, 2024, 16 (14)